Chris, I had MNKD a ways back, rode it from $2.25
Post# of 30028
I think Afrezza could be a life changer, but after getting burned on ARNA buying post approval, I will look to see final FDA approval and then buy after the pullback. Of course, that could be a the same levels it is today, but my powder is tied up. Much like Belviq, Afrezza will face reimbursement hurdles for several months and that's when uninformed investors will bail, not understanding the ramp up process for a new drug. I may actually sell all my ARNA and dump it in MNKD at that point.